Assyro AI

FDA Orange Book · active-ingredient family

Benzgalantamine gluconate

Benzgalantamine gluconate is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:ZUNVEYL · NDA 218549

1

Brand (NDA)

0

Generics (ANDA)

4

Listed patents

0

Exclusivity periods

Brand (NDA) products · tablet, delayed release

ProductApplicantApplicationTEApproved
ZUNVEYLRLD×3ALPHA COGNITIONNDA 218549Jul 26, 2024

Listed patents (4)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
9763953Dec 01, 2026in 6 mo
U-713
11795176Jan 13, 2042in 15 yr 10 mo
SubstanceU-713
12208167Feb 26, 2044in 17 yr 11 mo
ProductU-713
12551491Jul 23, 2045in 19 yr 4 mo
U-713

Benzgalantamine gluconate — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.